BlackRock Health Sciences Term Trust (NYSE:BMEZ) Shares Acquired by Oppenheimer & Co. Inc.

Oppenheimer & Co. Inc. lifted its stake in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZFree Report) by 13.7% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 75,163 shares of the company’s stock after acquiring an additional 9,082 shares during the period. Oppenheimer & Co. Inc.’s holdings in BlackRock Health Sciences Term Trust were worth $1,083,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also modified their holdings of BMEZ. Sunbelt Securities Inc. purchased a new position in shares of BlackRock Health Sciences Term Trust during the 1st quarter worth approximately $28,000. MUFG Americas Holdings Corp acquired a new stake in BlackRock Health Sciences Term Trust during the 3rd quarter worth approximately $30,000. Harbour Investments Inc. acquired a new stake in BlackRock Health Sciences Term Trust during the 4th quarter worth approximately $89,000. Carmel Capital Partners LLC acquired a new stake in BlackRock Health Sciences Term Trust during the 3rd quarter worth approximately $92,000. Finally, HBK Sorce Advisory LLC acquired a new stake in BlackRock Health Sciences Term Trust during the 1st quarter worth approximately $251,000.

Insiders Place Their Bets

In other BlackRock Health Sciences Term Trust news, major shareholder Saba Capital Management, L.P. bought 93,967 shares of BlackRock Health Sciences Term Trust stock in a transaction on Monday, February 5th. The shares were bought at an average cost of 15.56 per share, for a total transaction of 1,462,126.52. Following the acquisition, the insider now directly owns 18,690,059 shares in the company, valued at 290,817,318.04. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders have acquired a total of 3,497,851 shares of company stock worth $50,686,441 in the last ninety days.

BlackRock Health Sciences Term Trust Trading Up 0.7 %

BlackRock Health Sciences Term Trust stock opened at 15.84 on Thursday. BlackRock Health Sciences Term Trust has a 52-week low of 12.93 and a 52-week high of 16.95. The company’s 50 day moving average is 14.84 and its two-hundred day moving average is 14.70.

BlackRock Health Sciences Term Trust Cuts Dividend

The firm also recently announced a monthly dividend, which will be paid on Thursday, February 29th. Shareholders of record on Thursday, February 15th will be issued a dividend of $0.09 per share. The ex-dividend date is Wednesday, February 14th. This represents a $1.08 dividend on an annualized basis and a yield of 6.82%.

BlackRock Health Sciences Term Trust Company Profile

(Free Report)

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.

Read More

Institutional Ownership by Quarter for BlackRock Health Sciences Term Trust (NYSE:BMEZ)

Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.